Unlike 'one-to-many' approaches, ICDMO's digital library-to-library screening evaluates pairwise interactions between two protein libraries (bait library A × prey library B). The platform runs in two tiers: MEGADOCK for fast initial docking, then AI-PPI for finer secondary analysis, narrowing a large candidate set down to a ranked shortlist. Whole-genome and transcription factor digital libraries are available as starting points. The output is a set of interaction hypotheses ranked by model confidence — no experimental material is needed for the computational phase, and confirmation still requires laboratory work.
The platform performs a "many-to-many" interaction screen by: (1) Modeling 3D protein structures for every gene in both libraries using AI-based structure prediction; (2) Running MEGADOCK all-to-all protein docking to generate initial interaction scores; (3) Applying the AI-PPI deep learning model for high-precision secondary analysis; (4) Delivering ranked interaction pairs with gene IDs, modeling scores, and binary interaction calls (1 = predicted interaction, 0 = no interaction), sorted by descending score. The total interaction score represents the predicted docking score between two proteins — higher score indicates greater likelihood of interaction.
Cross-library screening multiplies both the opportunity and the false-positive burden: a matrix of ten thousand pairs will contain high-scoring pairs by chance alone. We report score distributions and flag promiscuous entries rather than presenting the top of the matrix as a hit list. All pairs are hypotheses for experimental testing, and deliverables are for research use only.
These are the failure modes that produce confident-looking results which do not survive the next experiment. Each one is designed against rather than discovered afterwards.
Illustrative of the shape this work takes. Details are generalised, no client or target is identified, and scope and outcome vary with the system in question.
The results below were published by independent groups and are cited to show what these computational approaches have achieved in the literature. They are not ICDMO project results, and outcomes vary substantially between targets, datasets and programmes. We do not promise comparable results for any particular project.
In a landmark 2019 study, ~138 million make-on-demand compounds were docked against the dopamine D4 receptor. Of 549 compounds selected and tested, 122 were confirmed active — a 22% hit rate — including ligands in the sub-nanomolar range. The same work screened ~99 million compounds against AmpC β-lactamase, where 5 of 44 tested compounds were confirmed (11%), one of which was among the most potent non-covalent AmpC inhibitors reported at the time.
Lyu et al., Nature, 2019 ↗The same body of work showed that the probability of a compound being confirmed active increases as its docking rank improves, and that larger libraries push better-scoring molecules into the selected set. This is the practical argument for screening make-on-demand space rather than a physical catalogue — and also the reason scoring accuracy, not library size alone, remains the limiting factor.
Lyu et al., Nature, 2019 ↗Note: All services are for research use only and not intended for diagnostic or therapeutic purposes.
Our scientific team responds within 24 hours with a detailed technical proposal and pricing tailored to your research goals.
Contact Us Online Consultation